These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


328 related items for PubMed ID: 21697548

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Sex- and isoform-specific mechanism of neuroprotection by transgenic expression of P450 epoxygenase in vascular endothelium.
    Jia J, Davis CM, Zhang W, Edin ML, Jouihan S, Jia T, Bradbury JA, Graves JP, DeGraff LM, Lee CR, Ronnekleiv O, Wang R, Xu Y, Zeldin DC, Alkayed NJ.
    Exp Neurol; 2016 May; 279():75-85. PubMed ID: 26902473
    [Abstract] [Full Text] [Related]

  • 4. Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice.
    Deng Y, Edin ML, Theken KN, Schuck RN, Flake GP, Kannon MA, DeGraff LM, Lih FB, Foley J, Bradbury JA, Graves JP, Tomer KB, Falck JR, Zeldin DC, Lee CR.
    FASEB J; 2011 Feb; 25(2):703-13. PubMed ID: 21059750
    [Abstract] [Full Text] [Related]

  • 5. Vascular Endothelial Over-Expression of Human Soluble Epoxide Hydrolase (Tie2-sEH Tr) Attenuates Coronary Reactive Hyperemia in Mice: Role of Oxylipins and ω-Hydroxylases.
    Hanif A, Edin ML, Zeldin DC, Morisseau C, Falck JR, Nayeem MA.
    PLoS One; 2017 Feb; 12(1):e0169584. PubMed ID: 28056085
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Crosstalk between adenosine receptors and CYP450-derived oxylipins in the modulation of cardiovascular, including coronary reactive hyperemic response.
    Nayeem MA, Hanif A, Geldenhuys WJ, Agba S.
    Pharmacol Ther; 2022 Dec; 240():108213. PubMed ID: 35597366
    [Abstract] [Full Text] [Related]

  • 12. Endothelium-specific CYP2J2 overexpression attenuates age-related insulin resistance.
    Yang Y, Dong R, Chen Z, Hu D, Fu M, Tang Y, Wang DW, Xu X, Tu L.
    Aging Cell; 2018 Apr; 17(2):. PubMed ID: 29318723
    [Abstract] [Full Text] [Related]

  • 13. Cytochrome P450 2J2 is protective against global cerebral ischemia in transgenic mice.
    Li R, Xu X, Chen C, Yu X, Edin ML, Degraff LM, Lee CR, Zeldin DC, Wang DW.
    Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):68-78. PubMed ID: 23041291
    [Abstract] [Full Text] [Related]

  • 14. Differential effects of soluble epoxide hydrolase inhibition and CYP2J2 overexpression on postischemic cardiac function in aged mice.
    Chaudhary KR, Zordoky BN, Edin ML, Alsaleh N, El-Kadi AO, Zeldin DC, Seubert JM.
    Prostaglandins Other Lipid Mediat; 2013 Dec; 104-105():8-17. PubMed ID: 22922020
    [Abstract] [Full Text] [Related]

  • 15. CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice.
    Chen G, Xu R, Zhang S, Wang Y, Wang P, Edin ML, Zeldin DC, Wang DW.
    Am J Physiol Endocrinol Metab; 2015 Jan 15; 308(2):E97-E110. PubMed ID: 25389366
    [Abstract] [Full Text] [Related]

  • 16. Genetic markers in the EET metabolic pathway are associated with outcomes in patients with aneurysmal subarachnoid hemorrhage.
    Donnelly MK, Conley YP, Crago EA, Ren D, Sherwood PR, Balzer JR, Poloyac SM.
    J Cereb Blood Flow Metab; 2015 Feb 15; 35(2):267-76. PubMed ID: 25388680
    [Abstract] [Full Text] [Related]

  • 17. Increased epoxyeicosatrienoic acids and reduced soluble epoxide hydrolase expression in the preeclamptic placenta.
    Dalle Vedove F, Fava C, Jiang H, Zanconato G, Quilley J, Brunelli M, Guglielmi V, Vattemi G, Minuz P.
    J Hypertens; 2016 Jul 15; 34(7):1364-70. PubMed ID: 27115337
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of CYP2J2 provides protection against doxorubicin-induced cardiotoxicity.
    Zhang Y, El-Sikhry H, Chaudhary KR, Batchu SN, Shayeganpour A, Jukar TO, Bradbury JA, Graves JP, DeGraff LM, Myers P, Rouse DC, Foley J, Nyska A, Zeldin DC, Seubert JM.
    Am J Physiol Heart Circ Physiol; 2009 Jul 15; 297(1):H37-46. PubMed ID: 19429816
    [Abstract] [Full Text] [Related]

  • 19. Linoleic Acid Metabolite DiHOME Decreases Post-ischemic Cardiac Recovery in Murine Hearts.
    Bannehr M, Löhr L, Gelep J, Haverkamp W, Schunck WH, Gollasch M, Wutzler A.
    Cardiovasc Toxicol; 2019 Aug 15; 19(4):365-371. PubMed ID: 30725262
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.